Food Effect
Showing 26 - 50 of >10,000
Healthy Trial in Overland Park (TP-05 (lotilaner oral), fasted group, TP-05 (lotilaner oral), high-fat group, TP-05 (lotilaner
Active, not recruiting
- Healthy
- TP-05 (lotilaner oral), fasted group
- +2 more
-
Overland Park, KansasDr. Vince Clinical Research
Feb 14, 2023
Healthy Volunteers Trial in Zibo (HSK31858, tablet, Placebo, tablet)
Completed
- Healthy Volunteers
- HSK31858, tablet
- Placebo, tablet
-
Zibo, Shang Dong, ChinaPKUCare Luzhong Hospital
Dec 15, 2022
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)
Completed
- Healthy
- CT-L01 12.5/1,000 mg
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Acute Myeloid Leukemia in Children Trial (Clifutinib with fed state, Clifutinib with fasted state)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Clifutinib with fed state
- Clifutinib with fasted state
- (no location specified)
Jul 7, 2022
Ovarian Cancer Trial in Turku (KAND145, Placebo)
Not yet recruiting
- Ovarian Cancer
- KAND145
- Placebo
-
Turku, FinlandClinical Research Services Turku - CRST Oy
Sep 26, 2023
MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets)
Active, not recruiting
- Major Depressive Disorder (MDD)
- Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
-
Ahmedabad, Gujarat, IndiaCliantha Research Limited
Oct 24, 2022
Schizophrenia Trial in Saga-shi (OPC-34712FUM/ Brexpiprazole fumarate)
Recruiting
- Schizophrenia
- OPC-34712FUM/ Brexpiprazole fumarate
-
Saga-shi, JapanRainbow & Sea Hospital
Sep 6, 2023
Autoimmune Diseases Trial in Merthyr Tydfil (AX-158)
Active, not recruiting
- Autoimmune Diseases
-
Merthyr Tydfil, United KingdomSimbec-Orion
Dec 19, 2022
Inflammatory Bowel Disease Trial in Nedlands (HRS-7085 tablets, Placebo tablet)
Recruiting
- Inflammatory Bowel Disease
- HRS-7085 tablets
- Placebo tablet
-
Nedlands, Western Australia, AustraliaLinear Clinical Research
Dec 19, 2022
Helicobacter Pylori Infection Trial in Changchun (TNP-2198, TNP-2198 Placebo)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- TNP-2198 Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)
Completed
- Healthy Adult Participants
- Treatment A
- +2 more
-
Baltimore, MarylandBaltimore Parexel EPCU
Jan 19, 2023
Diabetic Nephropathy Trial in Changchun (HEC73077 tablets, HEC73077 tablets)
Recruiting
- Diabetic Nephropathy
- HEC73077 tablets
- HEC73077 placebo tablets
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Aug 5, 2022
Diabetes, Type 2 Trial in Seoul (HGR4113, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- HGR4113
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2022
HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))
Not yet recruiting
- HIV Infections
- Cabotegravir IR Formulation (reference)
- +2 more
- (no location specified)
Mar 8, 2023
Cognitive Disorders Trial in Leuven (SDI-118, Placebo)
Completed
- Cognitive Disorders
- SDI-118
- Placebo
-
Leuven, BelgiumCentre for Clinical Pharmacology, UZ Leuven
Aug 2, 2022
Solid Tumor Trial in Wuhu (Fuzuloparib)
Active, not recruiting
- Solid Tumor
-
Wuhu, Anhui, ChinaWannan Medical College Yijishan Hospital
Jul 28, 2022